Malignant plasma cells from patients with newly diagnosed MM express high levels of the CD1d, a nonpolymorphic β2-microglobulin associated and glycolipid-presenting human leukocyte antigen class I-like molecule. Here, CD1D is linked to Miyoshi myopathy.